With a lower value of 0.18 and a higher value of 0.48, the patients were divided into three groups with different prevalence risk of hepatic steatosis, facilitating clinicians assess the risk of NAFLD and distinct that whether elevated ALT level was caused by NAFLD. The gene discussed is GPT; the disease is fatty liver disease.